US: +1 646-781-8004 | Europe:+44-203-868-8738 | APAC:+91-744-778-0008

Next Generation Sequencing Services Market

Release date:

Sep-2021

Region:

global

Research Code:MRHC - 104341

Sku:MRHC - 104341

Next-generation Sequencing Services Market by Type (Targeted Sequencing, Exome, RNA-Seq, ChIP Sequencing), Technology (Sequencing by Synthesis, Nanopore, SMRT), Application (Clinical Diagnosis, Biomarker Discovery), & End User - Forecast to 2028

  • Report ID: MRHC - 104341
  • Pages: 190
  • Sep-2021
  • Formats*: PDF
  • Category: Healthcare
  • Delivery: 2 to 4 Hours
COVID-19

This report provides pre & post COVID-19 market estimates.

The Next-generation Sequencing Services Market is expected to grow at a CAGR of 20.4% from 2021 to 2028 to reach $14.1 billion by 2028. The growth of this market is mainly attributed to the reducing cost of NGS procedures, the development and approval of new targeted therapies, rising prevalence of cancer, partnerships between NGS service providers and pharmaceutical companies, high cost of sequencing infrastructure, and technological advancements in NGS. In addition, advancements in sequencing data analytics and the increasing applications of NGS in cancer and agri-genomics research are expected to offer significant growth opportunities for NGS service providers.

However, the availability of alternative technologies, lack of skilled professionals for sample preparation and analysis, and actionable mutations for precision medicine may restrain the growth of the NGS services market. Moreover, regulatory & standardization concerns in diagnostic testing and the ethical issues & costs related to non-invasive prenatal genetic testing are major challenges for the growth of this market.

                                                             Click here to: Get Free Sample Pages of this Report 

Impact of COVID-19 Pandemic on the NGS Services Market

The COVID-19 virus SARS-CoV-2 was quickly identified due to the power of next-generation sequencing. Advances in NGS allowed the sequencing of SARS-CoV-2 to be completed within hours. Information of the virus's genome sequence enabled the rapid development of diagnostic assays and other response tools. The monitoring of the disease's transmission, activity, and evolution was aided by continued genome sequencing.

Currently, the COVID-19 pandemic is still ongoing, with new viral variations emerging around the globe. The pandemic has highlighted the need to integrate genome sequencing into the practices of the global health community. Many countries are focused on the genomic sequencing of the COVID-19 virus. The sequencing data is important for studying and understanding viral mutations. The mutations occurring in the virus genome must be tracked, as they may reduce the efficacy of the current safety protocols, tests, vaccines, and clinical care. Hence, for the authorities to plan an accurate public health action, genome sequencing of the virus is very important. For instance, in February 2020, the Netherlands sequenced its first positive samples and initiated its public health action by analyzing genomic data. According to a McKinsey report, the U.S. sequenced around 200,000 of its COVID-19 cases, while the U.K. sequenced 350,000 cases.

Furthermore, to enhance the genomic sequencing capabilities, the U.S. government allocated USD 1.7 billion to the CDC from the American Rescue Plan of 2021. Efforts are also being taken to sequence and analyze SARS-CoV-2 genomes by expanding the capacities of public health laboratories and establishing partnerships with academia and the private sector. The CDC has collaborated with several labs such as Laboratory Corporation of America Holdings (U.S.) and Quest Diagnostics (U.S.), as well as sequencing equipment manufacturers such as Illumina, Inc. (U.S.) to increase the country's sequencing capacity.

In August 2021, the Indian Ministry of Science and Technology announced a collaborative approach under the BRICS- multilateral research and development project. In this collaborative research, scientists from India, China, Russia, and Brazil will carry out the whole genome sequencing of SARS-CoV-2 and work on the epidemiology and mathematical modeling of the COVID-19 pandemic.

Furthermore, many NGS-based diagnostic tests were also developed. For instance, in June 2020, COVIDSeq, an NGS-based test from Illumina Inc. (U.S.), received emergency use authorization from the U.S. FDA for the qualitative detection and diagnosis of COVID-19. Similarly, NGS-based tests such as LamPORE by Oxford Nanopore Technologies Limited (U.K.) and SwabSeq by Octant, Inc. (U.S.) have been developed to diagnose COVID-19. NGS diagnostics are currently utilized in a relatively limited way, but they may become more frequently utilized in the future if they receive regulatory approvals from many countries and are demonstrated to be more effective than other testing methods.

There is a huge scope for the growth of the NGS services market as more countries implement sequencing programs to better understand emerging pathogens and their interactions with humans and animals.

Key Findings in the Global Next-generation Sequencing Services Market Study

The exome sequencing services segment is expected to grow at the highest CAGR during the forecast period

Based on type, the global NGS services market is segmented into targeted sequencing services, whole-genome sequencing services, RNA sequencing services, exome sequencing services, de novo sequencing services, ChIP sequencing services, methyl sequencing services, and other NGS services. The exome sequencing services segment is expected to grow at the highest CAGR during the forecast period. The advantages of exome sequencing, such as being a comparatively cost-effective alternative to whole-genome sequencing while achieving comprehensive coverage of coding regions, drive the growth of this market. Exomes are protein-coding genes estimated to encompass approximately 1% of the whole genome yet contain approximately 85% of disease-causing mutations.

The single-molecule real-time sequencing segment is expected to grow at the highest CAGR during the forecast period

Based on technology, the global NGS services market is segmented into sequencing by synthesis (SBS), ion semiconductor sequencing (IOS), single-molecule real-time sequencing (SMRT), nanopore sequencing, and other NGS technologies. The single-molecule real-time sequencing segment is expected to grow at the highest CAGR during the forecast period. The ability of this technology to provide highly accurate long reads with single-molecule resolutions drives the growth of this segment. Single-molecule real-time (SMRT) sequencing technology is based on directly observing a single strand of DNA synthesis. SMRT sequencing not only reports which nucleotides the polymerase incorporates but also records the polymerase kinetics.

The biomarker discovery segment is expected to grow at the highest CAGR during the forecast period

Based on application, the global NGS services market is segmented into biomarker discovery, diagnostics, drug discovery, agriculture & animal research, and other applications. The biomarker discovery segment is expected to grow at the highest CAGR during the forecast period. The advantages of NGS in discovering biomarkers, such as its high sensitivity and throughput and the rising importance of biomarker discovery in predicting and monitoring diseases, such as cancer and other chronic diseases, support the growth of this segment. Biomarkers are valuable for early diagnosis, prediction, and monitoring of the therapeutic efficacy of medicine and are particularly important in personalized medicine.

In 2021, the hospitals & clinics segment is estimated to account for the largest share of the global NGS services market

Based on end user, the global NGS services market is segmented into hospitals & clinics, pharmaceutical & biotechnology companies, academic & research institutes, and other end users. In 2021, the hospitals & clinics segment is estimated to account for the largest share of the global NGS services market. The large share of this segment is attributed to factors such as high capital requirements for building in-house NGS capabilities in hospitals & clinics, the rising prevalence of cancer and other chronic diseases, the growing demand for advanced medical treatments, and the rising number of biomarker-based therapies.

In 2021, North America is estimated to account for the largest share of the global NGS services market

Based on region, the NGS services market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. In 2021, North America is estimated to account for the largest share of the global NGS services market. The large share of North America in the NGS services market is primarily attributed to the presence of leading NGS service providers in the region, favorable government initiatives for genomics research, growing applications of NGS-based research, declining cost of sequencing coupled with the rising awareness of NGS, increasing research investments by pharmaceutical and biopharmaceutical companies, increasing cancer prevalence, and favorable reimbursement scenario in the region.

Key Players

The report includes a competitive landscape based on an extensive assessment of the key strategic developments that market participants adopted over the past four years. The key players profiled in the global next-generation sequencing services market report include Illumina, Inc. (U.S.), Qiagen N.V. (Netherland), PerkinElmer, Inc. (U.S.), Eurofins Scientific S.E. (Luxembourg), Macrogen, Inc. (South Korea), LGC Limited (U.K.), GENEWIZ, Inc. (U.S.), Beijing Genomics Institute (BGI) (China), SciGenom Labs Pvt. Ltd (India), MedGenome Inc. (U.S.), DNA Link, Inc. (South Korea), Otogenetics Corporation (U.S.), Novogene Co., Ltd. (China), CD Genomics (U.S.), Foundation Medicine, Inc. (U.S), and SeqLL, Inc. (U.S.).

Scope of the Report

NGS Services Market, by Type

  • Targeted Sequencing Services
  • RNA Sequencing Services
  • De Novo Sequencing Services
  • Exome Sequencing Services
  • Chip Sequencing Services
  • Whole-genome Sequencing Services
  • Methyl Sequencing Services
  • Other Services

NGS Services Market, by Technology

  • Sequencing By Synthesis (SBS)
  • Ion Semiconductor Sequencing (IOS)
  • Single-molecule Real-time Sequencing (SMRT)
  • Nanopore Sequencing
  • Other Technologies

NGS Services Market, by Application

  • Diagnostics
  • Drug Discovery
  • Biomarker Discovery
  • Agriculture & Animal Research
  • Other Applications

NGS Services Market, by End User

  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Academics & Research Institutes
  • Other End Users

NGS Services Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • Japan
    • China
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa

Key questions answered in the report:

What is the focus of the global next-generation sequencing services market?

The global next-generation sequencing services market covers the market size & forecasts the various NGS services used by hospitals & clinics, pharmaceutical & biotechnology companies, academics & research institutes, and other end users for diagnostics, drug discovery, biomarker discovery, agriculture & animal research, and other applications. The next-generation sequencing services market studied in this report involves the value analysis of various segments and sub-segments of NSG services at regional and country levels.

What is the value of revenue generated from NGS services across the globe? At what rate is their demand expected to grow for the next 5-7 years?

The next-generation sequencing services market is projected to reach $14.1 billion by 2028, at a CAGR of 20.4% during the forecast period.

Which type segment is estimated to hold the major share of the market?

The target sequencing services segment is estimated to account for the largest share of the next-generation sequencing services market in 2021. The large share of this segment is mainly attributed to the relatively lower cost, faster turnaround time, and accurate & easy-to-interpret results for studies of disease-related genes.

Which technology segment is projected to create more traction in the next-generation sequencing services market?

The single-molecule real-time sequencing (SMRT) segment is estimated to register the fastest CAGR during the forecast period due to the advantages of this technology to provide highly accurate long reads with single-molecule resolution.

What are the key factors supporting the growth of this market? Also, what are the major opportunities for existing market players and new entrants in the global next-generation sequencing services market?

The plummeting cost of NGS sequencing procedures, development and approval of new targeted therapies, rising prevalence of cancer, partnerships between NGS service providers and pharma companies, high cost of sequencing infrastructure, and technological advancements in NGS services have been considered to have a positive impact on the next-generation sequencing services market. In addition, the increasing application of NGS in cancer and agri-genomics research and advancements in sequencing data analytics provides significant opportunities for the next-generation sequencing service providers.

Who are the major players operating in the global next-generation sequencing services market?

Key companies operating in the global next-generation sequencing services market are Illumina, Inc. (U.S.), QIAGEN N.V. (Netherland), PerkinElmer, Inc. (U.S.), Eurofins Scientific S.E. (Luxembourg), Macrogen, Inc. (South Korea), LGC Limited (U.K.), GENEWIZ, Inc. (U.S.), Beijing Genomics Institute (BGI) (China), SciGenom Labs Pvt. Ltd (India), MedGenome Inc. (U.S.), DNA Link, Inc. (South Korea), Otogenetics Corporation (U.S.), Novogene Co., Ltd. (China), CD Genomics (U.S.), Foundation Medicine, Inc. (U.S), and SeqLL, Inc. (U.S.).

Which regions/countries are expected to offer significant growth opportunities for players operating in the next-generation sequencing services market?

Emerging economies like China and India are projected to offer significant growth opportunities for players in this market. Improvement in the healthcare infrastructure, rising research and development activities, and growing number of patients suffering from gene-associated disorders are the factors that will offer significant growth opportunities in this region.

1.    Introduction
       1.1.    Market Definition
       1.2.    Market Ecosystem
       1.3.    Currency
       1.4.    Key Stakeholders

2.    Research Methodology
       2.1.    Research Process
       2.2.    Data Collection & Validation
                 2.2.1.    Secondary Research
                 2.2.2.    Primary Research
       2.3.    Market Assessment                 
                 2.3.1.    Market Size Estimation
                              2.3.1.1.    Bottom-Up Approach
                              2.3.1.2.    Top-Down Approach
                              2.3.1.3.    Growth Forecast
                 2.3.2.    Market Share Analysis
       2.4.    Assumptions for This Study
       2.5.    Limitations for The Study

3.    Executive Summary

4.    Market Insights
       4.1.    Market Overview
       4.2.    Drivers
                 4.2.1.    Plummeting Costs of Sequencing Procedures
                 4.2.2.    Development and Approval of New Targeted Therapies
                 4.2.3.    Rising Prevalence of Cancer
                 4.2.4.    Partnerships Between NGS Service Providers and Pharmaceutical Companies
                 4.2.5.    High Cost of Sequencing Infrastructure
                 4.2.6.    Technological Advancements in NGS
       4.3.    Restraints
                 4.3.1.    Availability of Alternative Technologies
                 4.3.2.    Lack of Skilled Professionals for Sample Preparation and Analysis
                 4.3.3.    Low Chances of Positive Actionable Mutations for Precision Medicine
       4.4.    Opportunities
                 4.4.1.    Increasing Applications in Cancer and Agri-Genomics Research
                 4.4.2.    Advancements in Sequencing Data Analytics
       4.5.    Challenges
                 4.5.1.    Regulatory & Standardization Concerns in Diagnostic Testing
                 4.5.2.    Installation of In-House NGS Facilities in Large Hospitals and Research Institutes
                 4.5.3.    Ethical Issues & Costs Related to Non-Invasive Prenatal Genetic Testing
       4.6.    The Impact of Covid-19 on The Global NGS Services Market

5.    Global Next-Generation Sequencing Services Market, by Type
        5.1.    Introduction
        5.2.    Targeted Sequencing Services
        5.3.    RNA Sequencing Services
        5.4.    De Novo Sequencing Services
        5.5.    Exome Sequencing Services
        5.6.    Chip Sequencing Services
        5.7.    Methyl Sequencing Services
        5.8.    Whole-Genome Sequencing Services
        5.9.    Other NGS Services

6.    Global Next-Generation Sequencing Services Market, by Technology
        6.1.    Introduction
        6.2.    Sequencing by Synthesis (SBS)
        6.3.    Ion Semiconductor Sequencing (IOS)
        6.4.    Single-Molecule Real-Time (SMRT) Sequencing
        6.5.    Nanopore Sequencing
        6.6.    Other NGS Technologies

7.    Global Next-Generation Sequencing Services Market, by Application
        7.1.    Introduction
        7.2.    Diagnostics
        7.3.    Drug Discovery
        7.4.    Biomarker Discovery
        7.5.    Agriculture & Animal Research
        7.6.    Other Applications

8.    Global Next-Generation Sequencing Services Market, by End User
        8.1.    Introduction
        8.2.    Hospitals & Clinics
        8.3.    Pharmaceutical & Biotechnology Companies
        8.4.    Academics & Research Institutes
        8.5.    Other End Users

9.    Global NGS Services Market, by Geography
        9.1.    Introduction
        9.2.    North America
                 9.2.1.    U.S.
                 9.2.2.    Canada
        9.3.    Europe
                 9.3.1.    Germany
                 9.3.2.    France
                 9.3.3.    U.K.
                 9.3.4.    Italy
                 9.3.5.    Spain
                 9.3.6.    Rest of Europe (RoE)
        9.4.    Asia-Pacific
                 9.4.1.    Japan
                 9.4.2.    China
                 9.4.3.    India
                 9.4.4.    Rest of Asia-Pacific (RoAPAC)
        9.5.    Latin America
        9.6.    Middle East & Africa

10.    Competitive Landscape
         10.1.    Introduction
         10.2.    Key Growth Strategies
         10.3.    Competitive Benchmarking
         10.4.    Market Share Analysis (2020)
                     10.4.1.    Eurofins Scientific S.E.
                     10.4.2.    Illumina, Inc.
                     10.4.3.    Perkinelmer, Inc.
                     10.4.4.    GENEWIZ, Inc.
                     10.4.5.    Foundation Medicine, Inc. (Subsidiary of F. Hoffmann-La Roche AG)

11.    Company Profiles
         11.1.    Illumina, Inc.
                     11.1.1.    Business Overview
                     11.1.2.    Financial Overview
                     11.1.3.    Service Portfolio
                     11.1.4.    Strategic Developments
         11.2.    QIAGEN N.V.
                     11.2.1.    Business Overview
                     11.2.2.    Financial Overview
                     11.2.3.    Service Portfolio
         11.3.    PerkinElmer, Inc.
                     11.3.1.    Business Overview
                     11.3.2.    Financial Overview
                     11.3.3.    Service Portfolio
         11.4.    Eurofins Scientific S.E.
                     11.4.1.    Business Overview
                     11.4.2.    Financial Overview
                     11.4.3.    Service Portfolio
                     11.4.4.    Strategic Developments
         11.5.    Macrogen, Inc.
                     11.5.1.    Company Overview
                     11.5.2.    Financial Overview
                     11.5.3.    Service Portfolio
                     11.5.4.    Strategic Developments
         11.6.    LGC Limited
                     11.6.1.    Business Overview
                     11.6.2.    Financial Overview
                     11.6.3.    Service Portfolio
                     11.6.4.    Strategic Developments
         11.7.    GENEWIZ, Inc.
                     11.7.1.    Business Overview
                     11.7.2.    Financial Overview
                     11.7.3.    Service Portfolio
                     11.7.4.    Strategic Developments
         11.8.    Beijing Genomics Institute (BGI)
                     11.8.1.    Business Overview
                     11.8.2.    Service Portfolio
                     11.8.3.    Strategic Developments
         11.9.    Scigenom Labs Pvt., Ltd.
                     11.9.1.    Business Overview
                     11.9.2.    Service Portfolio
         11.10.    Medgenome Inc.
                     11.10.1.    Business Overview
                     11.10.2.    Service Portfolio
                     11.10.3.    Strategic Developments
         11.11.    DNA Link, Inc.
                     11.11.1.    Business Overview
                     11.11.2.    Service Portfolio
         11.12.    Otogenetics Corporation
                     11.12.1.    Business Overview
                     11.12.2.    Service Portfolio
         11.13.    Novogene Co., Ltd.
                     11.13.1.    Business Overview
                     11.13.2.    Service Portfolio
                     11.13.3.    Strategic Developments
         11.14.    CD Genomics
                     11.14.1.    Business Overview
                     11.14.2.    Service Portfolio
                     11.14.3.    Strategic Developments
         11.15.    SeqLL Inc.
                     11.15.1.    Business Overview
                     11.15.2.    Financial Overview
                     11.15.3.    Service Portfolio
         11.16.    Foundation Medicine, Inc. (Subsidiary of F. Hoffmann-La Roche AG)
                     11.16.1.    Business Overview
                     11.16.2.    Financial Overview
                     11.16.3.    Service Portfolio
                     11.16.4.    Strategic Developments

12.    Appendix
         12.1.    Questionnaire
         12.2.    Available Customization

List of Tables

Table 1    NGS Services Market Drivers: Impact Analysis (2021–2028)
Table 2    Currently Available Targeted Therapies and Corresponding Biomarkers
Table 3    Estimated Number of New Cancer Cases, by Type (2020)
Table 4    NGS Services Market Restraints: Impact Analysis (2021–2028)
Table 5    Global NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 6    Global Targeted Sequencing Services Market Size, by Country/Region, 2019–2028 (USD Million)
Table 7    Global RNA Sequencing Services Market Size, by Country/Region, 2019–2028 
(USD Million)
Table 8    Global De Novo Sequencing Services Market Size, by Country/Region, 2019–2028 (USD Million)
Table 9    Global Exome Sequencing Services Market Size, by Country/Region, 2019–2028 
(USD Million)
Table 10    Global Chip Sequencing Services Market Size, by Country/Region, 2019–2028 (USD Million)
Table 11    Global Methyl Sequencing Services Market Size, by Country/Region, 2019–2028 (USD Million)
Table 12    Global Whole-Genome Sequencing Services Market Size, by Country/Region, 2019–2028 (USD Million)
Table 13    Global Other NGS Services Market Size, by Country/Region, 2019–2028 (USD Million)
Table 14    Global NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 15    Global Sbs-based NGS Services Market Size, by Country/Region, 2019–2028 (USD Million)
Table 16    Global Ios-based NGS Services Market Size, by Country/Region, 2019–2028 (USD Million)
Table 17    Global Smart Technology-based NGS Services Market Size, by Country/Region, 2019–2028 (USD Million)
Table 18    Global Nanopore Technology-based NGS Services Market Size, by Country/Region, 2019–2028 (USD Million)
Table 19    Global Other Technologies-based NGS Services Market Size, by Country/Region, 2019–2028 (USD Million)
Table 20    Global NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 21    Global NGS Services Market Size for Diagnostics, by Country/Region, 2019–2028 (USD Million)
Table 22    Global NGS Services Market Size for Drug Discovery, by Country/Region, 2019–2028 (USD Million)
Table 23    Tumor Markers in Different Cancer Types
Table 24    Global NGS Services Market Size for Biomarker Discovery, by Country/Region, 2019–2028 (USD Million)
Table 25    Global NGS Services Market Size for Agriculture & Animal Research, by Country/Region, 2019–2028 (USD Million)
Table 26    Global NGS Services Market Size for Other Applications, by Country/Region, 2019–2028 (USD Million)
Table 27    Global NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 28    Global NGS Services Market Size for Hospitals & Clinics, by Country/Region, 2019–2028 (USD Million)
Table 29    Global NGS Services Market Size for Pharmaceutical & Biotechnology Companies, by Country/Region, 2019–2028 (USD Million)
Table 30    Global NGS Services Market Size for Academic & Research Institutes, by Country/Region, 2019–2028 (USD Million)
Table 31    Global NGS Services Market Size for Other End Users, by Country/Region, 2019–2028 (USD Million)
Table 32    Global NGS Services Market Size, by Country/Region, 2019–2028 (USD Million)
Table 33    North America: NGS Services Market Size, by Country, 2019–2028 (USD Million)
Table 34    North America: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 35    North America: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 36    North America: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 37    North America: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 38    U.S.: Key Macroindicators
Table 39    U.S.: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 40    U.S.: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 41    U.S.: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 42    U.S.: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 43    Canada: Key Macroindicators
Table 44    Canada: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 45    Canada: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 46    Canada: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 47    Canada: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 48    Europe: NGS Services Market Size, by Country/Region, 2019–2028 (USD Million)
Table 49    Europe: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 50    Europe: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 51    Europe: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 52    Europe: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 53    Germany: Key Macroindicators
Table 54    Germany: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 55    Germany: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 56    Germany: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 57    Germany: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 58    France: Key Macroindicators
Table 59    France: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 60    France: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 61    France: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 62    France: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 63    U.K.: Key Macroindicators
Table 64    U.K.: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 65    U.K.: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 66    U.K.: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 67    U.K.: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 68    Italy: Key Macroindicators
Table 69    U.K.: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 70    Italy: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 71    Italy: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 72    Italy: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 73    Spain: Key Macroindicators
Table 74    Spain: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 75    Spain: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 76    Spain: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 77    Spain: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 78    Estimated Number of New Cancer Cases From 2020 To 2030
Table 79    Roe: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 80    Roe: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 81    Roe: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 82    Roe: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 83    Asia-Pacific: NGS Services Market Size, by Country/Region, 2019–2028 (USD Million)
Table 84    Asia-Pacific: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 85    Asia-Pacific: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 86    Asia-Pacific: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 87    Asia-Pacific: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 88    Japan: Key Macroindicators
Table 89    Japan: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 90    Japan: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 91    Japan: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 92    Japan: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 93    China: Key Macroindicators
Table 94    China: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 95    China: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 96    China: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 97    China: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 98    India: Key Macroindicators
Table 99    India: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 100    India: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 101    India: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 102    India: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 103    Estimated Number of New Cancer Cases From 2020 To 2030
Table 104    Roapac: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 105    Roapac: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 106    Roapac: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 107    Roapac: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 108    Latin America: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 109    Latin America: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 110    Latin America: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 111    Latin America: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 112    Middle East & Africa: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 113    Middle East & Africa: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 114    Middle East & Africa: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 115    Middle East & Africa: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 116    Recent Developments, by Company, 2018—2021

List of Figures

Figure 1    Research Process
Figure 2    Key Secondary Sources
Figure 3    Primary Research Techniques
Figure 4    Key Executives Interviewed
Figure 5    Breakdown of Primary Interviews (Supply-Side & Demand-Side)
Figure 6    Market Size Estimation
Figure 7    Global Next-generation Sequencing Services Market Size, by Application, 2021 Vs. 2028 (USD Million)
Figure 8    Global Next-generation Sequencing Services Market Size, by Type, 2021 Vs. 2028 (USD Million)
Figure 9    Global Next-generation Sequencing Services Market Size, by Technology, 2021 Vs. 2028 (USD Million)
Figure 10    Global Next-generation Sequencing Services Market Size, by End User, 2021 Vs. 2028 (USD Million)
Figure 11    Next-generation Sequencing Services Market, by Geography
Figure 12    Market Dynamics
Figure 13    Cost of Genome Sequencing: 2010–2020
Figure 14    Global NGS Services Market Size, by Type, 2021–2028 (USD Million)
Figure 15    Number of Manuscripts Featuring RNA Sequencing Per Year on Pubmed
Figure 16    Global NGS Services Market Size, by Technology, 2021–2028 (USD Million)
Figure 17    Global NGS Services Market Size, by Application, 2021–2028 (USD Million)
Figure 18    New Molecular Entity (NME) Approvals Per Year
Figure 19    Global NGS Services Market Size, by End User, 2021–2028 (USD Million)
Figure 20    Global Biopharmaceutical R&D Spending, 2014–2020 (USD Billion)
Figure 21    Global NGS Services Market Size, by Geography, 2021–2028 (USD Million)
Figure 22    North America: NGS Services Market Snapshot
Figure 23    Pharmaceutical R&D Expenditure in the U.S.
Figure 24    Pharmaceutical Industry Research and Development in Europe (2019)
Figure 25    Europe: NGS Services Market Snapshot
Figure 26    Number of Biotechnology Firms in Italy, 2008-2019
Figure 27    R&D Spending by Pharmaceutical Industry in Spain, 2015-2019 (USD Million)
Figure 28    Pharmaceutical R&D Spending in Roe (2019)
Figure 29    Asia-Pacific: NGS Services Market Snapshot
Figure 30    Key Growth Strategies Adopted by Leading Players, 2018—2021
Figure 31    NGS Services: Competitive Benchmarking (Based on Service Type)
Figure 32    NGS Services: Competitive Benchmarking (Based on Geography)
Figure 33    Market Share Analysis: NGS Services Industry, 2020
Figure 34    Illumina, Inc.: Financial Overview, 2020
Figure 35    Qiagen N.V.: Financial Overview, 2020
Figure 36    Perkinelmer, Inc.: Financial Overview, 2020
Figure 37    Eurofins Scientific S.E.: Financial Overview, 2020
Figure 38    Macrogen, Inc.: Financial Overview, 2020
Figure 39    LGC Limited: Financial Overview, 2020
Figure 40    Brooks Automation, Inc.: Financial Overview, 2020
Figure 41    SeqLL Inc.: Financial Overview, 2020
Figure 42    F. Hoffmann-La Roche AG.: Financial Overview, 2020

 
Name can only consist of alphabets.
Please provide your full name.
 
Please provide valid email address.
Please provide your email address.
 
Please provide your job title.
 
Please provide your company name.
 
Please provide your company name.
 
Please provide valid phone number.
Please provide your phone number.
 
Please enter minimum 10 characters.
 
Please enter Captcha.
Please enter valid Captcha.

This website is secure and we do not share your personal information with any third party. Privacy Policy

Related Research

The Next-generation Sequencing Services Market is expected to grow at a CAGR of 20.4% from 2021 to 2028 to reach $14.1 billion by 2028. The growth of this market is mainly attributed to the reducing cost of NGS procedures, the development and approval of new targeted therapies, rising prevalence of cancer, partnerships between NGS service providers and pharmaceutical companies, high cost of sequencing infrastructure, and technological advancements in NGS. In addition, advancements in sequencing data analytics and the increasing applications of NGS in cancer and agri-genomics research are expected to offer significant growth opportunities for NGS service providers.

However, the availability of alternative technologies, lack of skilled professionals for sample preparation and analysis, and actionable mutations for precision medicine may restrain the growth of the NGS services market. Moreover, regulatory & standardization concerns in diagnostic testing and the ethical issues & costs related to non-invasive prenatal genetic testing are major challenges for the growth of this market.

                                                             Click here to: Get Free Sample Pages of this Report 

Impact of COVID-19 Pandemic on the NGS Services Market

The COVID-19 virus SARS-CoV-2 was quickly identified due to the power of next-generation sequencing. Advances in NGS allowed the sequencing of SARS-CoV-2 to be completed within hours. Information of the virus's genome sequence enabled the rapid development of diagnostic assays and other response tools. The monitoring of the disease's transmission, activity, and evolution was aided by continued genome sequencing.

Currently, the COVID-19 pandemic is still ongoing, with new viral variations emerging around the globe. The pandemic has highlighted the need to integrate genome sequencing into the practices of the global health community. Many countries are focused on the genomic sequencing of the COVID-19 virus. The sequencing data is important for studying and understanding viral mutations. The mutations occurring in the virus genome must be tracked, as they may reduce the efficacy of the current safety protocols, tests, vaccines, and clinical care. Hence, for the authorities to plan an accurate public health action, genome sequencing of the virus is very important. For instance, in February 2020, the Netherlands sequenced its first positive samples and initiated its public health action by analyzing genomic data. According to a McKinsey report, the U.S. sequenced around 200,000 of its COVID-19 cases, while the U.K. sequenced 350,000 cases.

Furthermore, to enhance the genomic sequencing capabilities, the U.S. government allocated USD 1.7 billion to the CDC from the American Rescue Plan of 2021. Efforts are also being taken to sequence and analyze SARS-CoV-2 genomes by expanding the capacities of public health laboratories and establishing partnerships with academia and the private sector. The CDC has collaborated with several labs such as Laboratory Corporation of America Holdings (U.S.) and Quest Diagnostics (U.S.), as well as sequencing equipment manufacturers such as Illumina, Inc. (U.S.) to increase the country's sequencing capacity.

In August 2021, the Indian Ministry of Science and Technology announced a collaborative approach under the BRICS- multilateral research and development project. In this collaborative research, scientists from India, China, Russia, and Brazil will carry out the whole genome sequencing of SARS-CoV-2 and work on the epidemiology and mathematical modeling of the COVID-19 pandemic.

Furthermore, many NGS-based diagnostic tests were also developed. For instance, in June 2020, COVIDSeq, an NGS-based test from Illumina Inc. (U.S.), received emergency use authorization from the U.S. FDA for the qualitative detection and diagnosis of COVID-19. Similarly, NGS-based tests such as LamPORE by Oxford Nanopore Technologies Limited (U.K.) and SwabSeq by Octant, Inc. (U.S.) have been developed to diagnose COVID-19. NGS diagnostics are currently utilized in a relatively limited way, but they may become more frequently utilized in the future if they receive regulatory approvals from many countries and are demonstrated to be more effective than other testing methods.

There is a huge scope for the growth of the NGS services market as more countries implement sequencing programs to better understand emerging pathogens and their interactions with humans and animals.

Key Findings in the Global Next-generation Sequencing Services Market Study

The exome sequencing services segment is expected to grow at the highest CAGR during the forecast period

Based on type, the global NGS services market is segmented into targeted sequencing services, whole-genome sequencing services, RNA sequencing services, exome sequencing services, de novo sequencing services, ChIP sequencing services, methyl sequencing services, and other NGS services. The exome sequencing services segment is expected to grow at the highest CAGR during the forecast period. The advantages of exome sequencing, such as being a comparatively cost-effective alternative to whole-genome sequencing while achieving comprehensive coverage of coding regions, drive the growth of this market. Exomes are protein-coding genes estimated to encompass approximately 1% of the whole genome yet contain approximately 85% of disease-causing mutations.

The single-molecule real-time sequencing segment is expected to grow at the highest CAGR during the forecast period

Based on technology, the global NGS services market is segmented into sequencing by synthesis (SBS), ion semiconductor sequencing (IOS), single-molecule real-time sequencing (SMRT), nanopore sequencing, and other NGS technologies. The single-molecule real-time sequencing segment is expected to grow at the highest CAGR during the forecast period. The ability of this technology to provide highly accurate long reads with single-molecule resolutions drives the growth of this segment. Single-molecule real-time (SMRT) sequencing technology is based on directly observing a single strand of DNA synthesis. SMRT sequencing not only reports which nucleotides the polymerase incorporates but also records the polymerase kinetics.

The biomarker discovery segment is expected to grow at the highest CAGR during the forecast period

Based on application, the global NGS services market is segmented into biomarker discovery, diagnostics, drug discovery, agriculture & animal research, and other applications. The biomarker discovery segment is expected to grow at the highest CAGR during the forecast period. The advantages of NGS in discovering biomarkers, such as its high sensitivity and throughput and the rising importance of biomarker discovery in predicting and monitoring diseases, such as cancer and other chronic diseases, support the growth of this segment. Biomarkers are valuable for early diagnosis, prediction, and monitoring of the therapeutic efficacy of medicine and are particularly important in personalized medicine.

In 2021, the hospitals & clinics segment is estimated to account for the largest share of the global NGS services market

Based on end user, the global NGS services market is segmented into hospitals & clinics, pharmaceutical & biotechnology companies, academic & research institutes, and other end users. In 2021, the hospitals & clinics segment is estimated to account for the largest share of the global NGS services market. The large share of this segment is attributed to factors such as high capital requirements for building in-house NGS capabilities in hospitals & clinics, the rising prevalence of cancer and other chronic diseases, the growing demand for advanced medical treatments, and the rising number of biomarker-based therapies.

In 2021, North America is estimated to account for the largest share of the global NGS services market

Based on region, the NGS services market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. In 2021, North America is estimated to account for the largest share of the global NGS services market. The large share of North America in the NGS services market is primarily attributed to the presence of leading NGS service providers in the region, favorable government initiatives for genomics research, growing applications of NGS-based research, declining cost of sequencing coupled with the rising awareness of NGS, increasing research investments by pharmaceutical and biopharmaceutical companies, increasing cancer prevalence, and favorable reimbursement scenario in the region.

Key Players

The report includes a competitive landscape based on an extensive assessment of the key strategic developments that market participants adopted over the past four years. The key players profiled in the global next-generation sequencing services market report include Illumina, Inc. (U.S.), Qiagen N.V. (Netherland), PerkinElmer, Inc. (U.S.), Eurofins Scientific S.E. (Luxembourg), Macrogen, Inc. (South Korea), LGC Limited (U.K.), GENEWIZ, Inc. (U.S.), Beijing Genomics Institute (BGI) (China), SciGenom Labs Pvt. Ltd (India), MedGenome Inc. (U.S.), DNA Link, Inc. (South Korea), Otogenetics Corporation (U.S.), Novogene Co., Ltd. (China), CD Genomics (U.S.), Foundation Medicine, Inc. (U.S), and SeqLL, Inc. (U.S.).

Scope of the Report

NGS Services Market, by Type

  • Targeted Sequencing Services
  • RNA Sequencing Services
  • De Novo Sequencing Services
  • Exome Sequencing Services
  • Chip Sequencing Services
  • Whole-genome Sequencing Services
  • Methyl Sequencing Services
  • Other Services

NGS Services Market, by Technology

  • Sequencing By Synthesis (SBS)
  • Ion Semiconductor Sequencing (IOS)
  • Single-molecule Real-time Sequencing (SMRT)
  • Nanopore Sequencing
  • Other Technologies

NGS Services Market, by Application

  • Diagnostics
  • Drug Discovery
  • Biomarker Discovery
  • Agriculture & Animal Research
  • Other Applications

NGS Services Market, by End User

  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Academics & Research Institutes
  • Other End Users

NGS Services Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • Japan
    • China
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa

Key questions answered in the report:

  Request Sample

1.    Introduction
       1.1.    Market Definition
       1.2.    Market Ecosystem
       1.3.    Currency
       1.4.    Key Stakeholders

2.    Research Methodology
       2.1.    Research Process
       2.2.    Data Collection & Validation
                 2.2.1.    Secondary Research
                 2.2.2.    Primary Research
       2.3.    Market Assessment                 
                 2.3.1.    Market Size Estimation
                              2.3.1.1.    Bottom-Up Approach
                              2.3.1.2.    Top-Down Approach
                              2.3.1.3.    Growth Forecast
                 2.3.2.    Market Share Analysis
       2.4.    Assumptions for This Study
       2.5.    Limitations for The Study

3.    Executive Summary

4.    Market Insights
       4.1.    Market Overview
       4.2.    Drivers
                 4.2.1.    Plummeting Costs of Sequencing Procedures
                 4.2.2.    Development and Approval of New Targeted Therapies
                 4.2.3.    Rising Prevalence of Cancer
                 4.2.4.    Partnerships Between NGS Service Providers and Pharmaceutical Companies
                 4.2.5.    High Cost of Sequencing Infrastructure
                 4.2.6.    Technological Advancements in NGS
       4.3.    Restraints
                 4.3.1.    Availability of Alternative Technologies
                 4.3.2.    Lack of Skilled Professionals for Sample Preparation and Analysis
                 4.3.3.    Low Chances of Positive Actionable Mutations for Precision Medicine
       4.4.    Opportunities
                 4.4.1.    Increasing Applications in Cancer and Agri-Genomics Research
                 4.4.2.    Advancements in Sequencing Data Analytics
       4.5.    Challenges
                 4.5.1.    Regulatory & Standardization Concerns in Diagnostic Testing
                 4.5.2.    Installation of In-House NGS Facilities in Large Hospitals and Research Institutes
                 4.5.3.    Ethical Issues & Costs Related to Non-Invasive Prenatal Genetic Testing
       4.6.    The Impact of Covid-19 on The Global NGS Services Market

5.    Global Next-Generation Sequencing Services Market, by Type
        5.1.    Introduction
        5.2.    Targeted Sequencing Services
        5.3.    RNA Sequencing Services
        5.4.    De Novo Sequencing Services
        5.5.    Exome Sequencing Services
        5.6.    Chip Sequencing Services
        5.7.    Methyl Sequencing Services
        5.8.    Whole-Genome Sequencing Services
        5.9.    Other NGS Services

6.    Global Next-Generation Sequencing Services Market, by Technology
        6.1.    Introduction
        6.2.    Sequencing by Synthesis (SBS)
        6.3.    Ion Semiconductor Sequencing (IOS)
        6.4.    Single-Molecule Real-Time (SMRT) Sequencing
        6.5.    Nanopore Sequencing
        6.6.    Other NGS Technologies

7.    Global Next-Generation Sequencing Services Market, by Application
        7.1.    Introduction
        7.2.    Diagnostics
        7.3.    Drug Discovery
        7.4.    Biomarker Discovery
        7.5.    Agriculture & Animal Research
        7.6.    Other Applications

8.    Global Next-Generation Sequencing Services Market, by End User
        8.1.    Introduction
        8.2.    Hospitals & Clinics
        8.3.    Pharmaceutical & Biotechnology Companies
        8.4.    Academics & Research Institutes
        8.5.    Other End Users

9.    Global NGS Services Market, by Geography
        9.1.    Introduction
        9.2.    North America
                 9.2.1.    U.S.
                 9.2.2.    Canada
        9.3.    Europe
                 9.3.1.    Germany
                 9.3.2.    France
                 9.3.3.    U.K.
                 9.3.4.    Italy
                 9.3.5.    Spain
                 9.3.6.    Rest of Europe (RoE)
        9.4.    Asia-Pacific
                 9.4.1.    Japan
                 9.4.2.    China
                 9.4.3.    India
                 9.4.4.    Rest of Asia-Pacific (RoAPAC)
        9.5.    Latin America
        9.6.    Middle East & Africa

10.    Competitive Landscape
         10.1.    Introduction
         10.2.    Key Growth Strategies
         10.3.    Competitive Benchmarking
         10.4.    Market Share Analysis (2020)
                     10.4.1.    Eurofins Scientific S.E.
                     10.4.2.    Illumina, Inc.
                     10.4.3.    Perkinelmer, Inc.
                     10.4.4.    GENEWIZ, Inc.
                     10.4.5.    Foundation Medicine, Inc. (Subsidiary of F. Hoffmann-La Roche AG)

11.    Company Profiles
         11.1.    Illumina, Inc.
                     11.1.1.    Business Overview
                     11.1.2.    Financial Overview
                     11.1.3.    Service Portfolio
                     11.1.4.    Strategic Developments
         11.2.    QIAGEN N.V.
                     11.2.1.    Business Overview
                     11.2.2.    Financial Overview
                     11.2.3.    Service Portfolio
         11.3.    PerkinElmer, Inc.
                     11.3.1.    Business Overview
                     11.3.2.    Financial Overview
                     11.3.3.    Service Portfolio
         11.4.    Eurofins Scientific S.E.
                     11.4.1.    Business Overview
                     11.4.2.    Financial Overview
                     11.4.3.    Service Portfolio
                     11.4.4.    Strategic Developments
         11.5.    Macrogen, Inc.
                     11.5.1.    Company Overview
                     11.5.2.    Financial Overview
                     11.5.3.    Service Portfolio
                     11.5.4.    Strategic Developments
         11.6.    LGC Limited
                     11.6.1.    Business Overview
                     11.6.2.    Financial Overview
                     11.6.3.    Service Portfolio
                     11.6.4.    Strategic Developments
         11.7.    GENEWIZ, Inc.
                     11.7.1.    Business Overview
                     11.7.2.    Financial Overview
                     11.7.3.    Service Portfolio
                     11.7.4.    Strategic Developments
         11.8.    Beijing Genomics Institute (BGI)
                     11.8.1.    Business Overview
                     11.8.2.    Service Portfolio
                     11.8.3.    Strategic Developments
         11.9.    Scigenom Labs Pvt., Ltd.
                     11.9.1.    Business Overview
                     11.9.2.    Service Portfolio
         11.10.    Medgenome Inc.
                     11.10.1.    Business Overview
                     11.10.2.    Service Portfolio
                     11.10.3.    Strategic Developments
         11.11.    DNA Link, Inc.
                     11.11.1.    Business Overview
                     11.11.2.    Service Portfolio
         11.12.    Otogenetics Corporation
                     11.12.1.    Business Overview
                     11.12.2.    Service Portfolio
         11.13.    Novogene Co., Ltd.
                     11.13.1.    Business Overview
                     11.13.2.    Service Portfolio
                     11.13.3.    Strategic Developments
         11.14.    CD Genomics
                     11.14.1.    Business Overview
                     11.14.2.    Service Portfolio
                     11.14.3.    Strategic Developments
         11.15.    SeqLL Inc.
                     11.15.1.    Business Overview
                     11.15.2.    Financial Overview
                     11.15.3.    Service Portfolio
         11.16.    Foundation Medicine, Inc. (Subsidiary of F. Hoffmann-La Roche AG)
                     11.16.1.    Business Overview
                     11.16.2.    Financial Overview
                     11.16.3.    Service Portfolio
                     11.16.4.    Strategic Developments

12.    Appendix
         12.1.    Questionnaire
         12.2.    Available Customization

List of Tables

Table 1    NGS Services Market Drivers: Impact Analysis (2021–2028)
Table 2    Currently Available Targeted Therapies and Corresponding Biomarkers
Table 3    Estimated Number of New Cancer Cases, by Type (2020)
Table 4    NGS Services Market Restraints: Impact Analysis (2021–2028)
Table 5    Global NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 6    Global Targeted Sequencing Services Market Size, by Country/Region, 2019–2028 (USD Million)
Table 7    Global RNA Sequencing Services Market Size, by Country/Region, 2019–2028 
(USD Million)
Table 8    Global De Novo Sequencing Services Market Size, by Country/Region, 2019–2028 (USD Million)
Table 9    Global Exome Sequencing Services Market Size, by Country/Region, 2019–2028 
(USD Million)
Table 10    Global Chip Sequencing Services Market Size, by Country/Region, 2019–2028 (USD Million)
Table 11    Global Methyl Sequencing Services Market Size, by Country/Region, 2019–2028 (USD Million)
Table 12    Global Whole-Genome Sequencing Services Market Size, by Country/Region, 2019–2028 (USD Million)
Table 13    Global Other NGS Services Market Size, by Country/Region, 2019–2028 (USD Million)
Table 14    Global NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 15    Global Sbs-based NGS Services Market Size, by Country/Region, 2019–2028 (USD Million)
Table 16    Global Ios-based NGS Services Market Size, by Country/Region, 2019–2028 (USD Million)
Table 17    Global Smart Technology-based NGS Services Market Size, by Country/Region, 2019–2028 (USD Million)
Table 18    Global Nanopore Technology-based NGS Services Market Size, by Country/Region, 2019–2028 (USD Million)
Table 19    Global Other Technologies-based NGS Services Market Size, by Country/Region, 2019–2028 (USD Million)
Table 20    Global NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 21    Global NGS Services Market Size for Diagnostics, by Country/Region, 2019–2028 (USD Million)
Table 22    Global NGS Services Market Size for Drug Discovery, by Country/Region, 2019–2028 (USD Million)
Table 23    Tumor Markers in Different Cancer Types
Table 24    Global NGS Services Market Size for Biomarker Discovery, by Country/Region, 2019–2028 (USD Million)
Table 25    Global NGS Services Market Size for Agriculture & Animal Research, by Country/Region, 2019–2028 (USD Million)
Table 26    Global NGS Services Market Size for Other Applications, by Country/Region, 2019–2028 (USD Million)
Table 27    Global NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 28    Global NGS Services Market Size for Hospitals & Clinics, by Country/Region, 2019–2028 (USD Million)
Table 29    Global NGS Services Market Size for Pharmaceutical & Biotechnology Companies, by Country/Region, 2019–2028 (USD Million)
Table 30    Global NGS Services Market Size for Academic & Research Institutes, by Country/Region, 2019–2028 (USD Million)
Table 31    Global NGS Services Market Size for Other End Users, by Country/Region, 2019–2028 (USD Million)
Table 32    Global NGS Services Market Size, by Country/Region, 2019–2028 (USD Million)
Table 33    North America: NGS Services Market Size, by Country, 2019–2028 (USD Million)
Table 34    North America: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 35    North America: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 36    North America: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 37    North America: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 38    U.S.: Key Macroindicators
Table 39    U.S.: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 40    U.S.: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 41    U.S.: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 42    U.S.: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 43    Canada: Key Macroindicators
Table 44    Canada: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 45    Canada: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 46    Canada: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 47    Canada: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 48    Europe: NGS Services Market Size, by Country/Region, 2019–2028 (USD Million)
Table 49    Europe: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 50    Europe: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 51    Europe: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 52    Europe: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 53    Germany: Key Macroindicators
Table 54    Germany: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 55    Germany: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 56    Germany: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 57    Germany: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 58    France: Key Macroindicators
Table 59    France: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 60    France: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 61    France: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 62    France: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 63    U.K.: Key Macroindicators
Table 64    U.K.: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 65    U.K.: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 66    U.K.: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 67    U.K.: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 68    Italy: Key Macroindicators
Table 69    U.K.: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 70    Italy: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 71    Italy: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 72    Italy: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 73    Spain: Key Macroindicators
Table 74    Spain: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 75    Spain: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 76    Spain: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 77    Spain: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 78    Estimated Number of New Cancer Cases From 2020 To 2030
Table 79    Roe: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 80    Roe: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 81    Roe: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 82    Roe: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 83    Asia-Pacific: NGS Services Market Size, by Country/Region, 2019–2028 (USD Million)
Table 84    Asia-Pacific: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 85    Asia-Pacific: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 86    Asia-Pacific: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 87    Asia-Pacific: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 88    Japan: Key Macroindicators
Table 89    Japan: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 90    Japan: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 91    Japan: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 92    Japan: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 93    China: Key Macroindicators
Table 94    China: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 95    China: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 96    China: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 97    China: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 98    India: Key Macroindicators
Table 99    India: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 100    India: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 101    India: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 102    India: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 103    Estimated Number of New Cancer Cases From 2020 To 2030
Table 104    Roapac: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 105    Roapac: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 106    Roapac: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 107    Roapac: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 108    Latin America: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 109    Latin America: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 110    Latin America: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 111    Latin America: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 112    Middle East & Africa: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 113    Middle East & Africa: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 114    Middle East & Africa: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 115    Middle East & Africa: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 116    Recent Developments, by Company, 2018—2021

List of Figures

Figure 1    Research Process
Figure 2    Key Secondary Sources
Figure 3    Primary Research Techniques
Figure 4    Key Executives Interviewed
Figure 5    Breakdown of Primary Interviews (Supply-Side & Demand-Side)
Figure 6    Market Size Estimation
Figure 7    Global Next-generation Sequencing Services Market Size, by Application, 2021 Vs. 2028 (USD Million)
Figure 8    Global Next-generation Sequencing Services Market Size, by Type, 2021 Vs. 2028 (USD Million)
Figure 9    Global Next-generation Sequencing Services Market Size, by Technology, 2021 Vs. 2028 (USD Million)
Figure 10    Global Next-generation Sequencing Services Market Size, by End User, 2021 Vs. 2028 (USD Million)
Figure 11    Next-generation Sequencing Services Market, by Geography
Figure 12    Market Dynamics
Figure 13    Cost of Genome Sequencing: 2010–2020
Figure 14    Global NGS Services Market Size, by Type, 2021–2028 (USD Million)
Figure 15    Number of Manuscripts Featuring RNA Sequencing Per Year on Pubmed
Figure 16    Global NGS Services Market Size, by Technology, 2021–2028 (USD Million)
Figure 17    Global NGS Services Market Size, by Application, 2021–2028 (USD Million)
Figure 18    New Molecular Entity (NME) Approvals Per Year
Figure 19    Global NGS Services Market Size, by End User, 2021–2028 (USD Million)
Figure 20    Global Biopharmaceutical R&D Spending, 2014–2020 (USD Billion)
Figure 21    Global NGS Services Market Size, by Geography, 2021–2028 (USD Million)
Figure 22    North America: NGS Services Market Snapshot
Figure 23    Pharmaceutical R&D Expenditure in the U.S.
Figure 24    Pharmaceutical Industry Research and Development in Europe (2019)
Figure 25    Europe: NGS Services Market Snapshot
Figure 26    Number of Biotechnology Firms in Italy, 2008-2019
Figure 27    R&D Spending by Pharmaceutical Industry in Spain, 2015-2019 (USD Million)
Figure 28    Pharmaceutical R&D Spending in Roe (2019)
Figure 29    Asia-Pacific: NGS Services Market Snapshot
Figure 30    Key Growth Strategies Adopted by Leading Players, 2018—2021
Figure 31    NGS Services: Competitive Benchmarking (Based on Service Type)
Figure 32    NGS Services: Competitive Benchmarking (Based on Geography)
Figure 33    Market Share Analysis: NGS Services Industry, 2020
Figure 34    Illumina, Inc.: Financial Overview, 2020
Figure 35    Qiagen N.V.: Financial Overview, 2020
Figure 36    Perkinelmer, Inc.: Financial Overview, 2020
Figure 37    Eurofins Scientific S.E.: Financial Overview, 2020
Figure 38    Macrogen, Inc.: Financial Overview, 2020
Figure 39    LGC Limited: Financial Overview, 2020
Figure 40    Brooks Automation, Inc.: Financial Overview, 2020
Figure 41    SeqLL Inc.: Financial Overview, 2020
Figure 42    F. Hoffmann-La Roche AG.: Financial Overview, 2020

  Request Sample

1.    Introduction
       1.1.    Market Definition
       1.2.    Market Ecosystem
       1.3.    Currency
       1.4.    Key Stakeholders

2.    Research Methodology
       2.1.    Research Process
       2.2.    Data Collection & Validation
                 2.2.1.    Secondary Research
                 2.2.2.    Primary Research
       2.3.    Market Assessment                 
                 2.3.1.    Market Size Estimation
                              2.3.1.1.    Bottom-Up Approach
                              2.3.1.2.    Top-Down Approach
                              2.3.1.3.    Growth Forecast
                 2.3.2.    Market Share Analysis
       2.4.    Assumptions for This Study
       2.5.    Limitations for The Study

3.    Executive Summary

4.    Market Insights
       4.1.    Market Overview
       4.2.    Drivers
                 4.2.1.    Plummeting Costs of Sequencing Procedures
                 4.2.2.    Development and Approval of New Targeted Therapies
                 4.2.3.    Rising Prevalence of Cancer
                 4.2.4.    Partnerships Between NGS Service Providers and Pharmaceutical Companies
                 4.2.5.    High Cost of Sequencing Infrastructure
                 4.2.6.    Technological Advancements in NGS
       4.3.    Restraints
                 4.3.1.    Availability of Alternative Technologies
                 4.3.2.    Lack of Skilled Professionals for Sample Preparation and Analysis
                 4.3.3.    Low Chances of Positive Actionable Mutations for Precision Medicine
       4.4.    Opportunities
                 4.4.1.    Increasing Applications in Cancer and Agri-Genomics Research
                 4.4.2.    Advancements in Sequencing Data Analytics
       4.5.    Challenges
                 4.5.1.    Regulatory & Standardization Concerns in Diagnostic Testing
                 4.5.2.    Installation of In-House NGS Facilities in Large Hospitals and Research Institutes
                 4.5.3.    Ethical Issues & Costs Related to Non-Invasive Prenatal Genetic Testing
       4.6.    The Impact of Covid-19 on The Global NGS Services Market

5.    Global Next-Generation Sequencing Services Market, by Type
        5.1.    Introduction
        5.2.    Targeted Sequencing Services
        5.3.    RNA Sequencing Services
        5.4.    De Novo Sequencing Services
        5.5.    Exome Sequencing Services
        5.6.    Chip Sequencing Services
        5.7.    Methyl Sequencing Services
        5.8.    Whole-Genome Sequencing Services
        5.9.    Other NGS Services

6.    Global Next-Generation Sequencing Services Market, by Technology
        6.1.    Introduction
        6.2.    Sequencing by Synthesis (SBS)
        6.3.    Ion Semiconductor Sequencing (IOS)
        6.4.    Single-Molecule Real-Time (SMRT) Sequencing
        6.5.    Nanopore Sequencing
        6.6.    Other NGS Technologies

7.    Global Next-Generation Sequencing Services Market, by Application
        7.1.    Introduction
        7.2.    Diagnostics
        7.3.    Drug Discovery
        7.4.    Biomarker Discovery
        7.5.    Agriculture & Animal Research
        7.6.    Other Applications

8.    Global Next-Generation Sequencing Services Market, by End User
        8.1.    Introduction
        8.2.    Hospitals & Clinics
        8.3.    Pharmaceutical & Biotechnology Companies
        8.4.    Academics & Research Institutes
        8.5.    Other End Users

9.    Global NGS Services Market, by Geography
        9.1.    Introduction
        9.2.    North America
                 9.2.1.    U.S.
                 9.2.2.    Canada
        9.3.    Europe
                 9.3.1.    Germany
                 9.3.2.    France
                 9.3.3.    U.K.
                 9.3.4.    Italy
                 9.3.5.    Spain
                 9.3.6.    Rest of Europe (RoE)
        9.4.    Asia-Pacific
                 9.4.1.    Japan
                 9.4.2.    China
                 9.4.3.    India
                 9.4.4.    Rest of Asia-Pacific (RoAPAC)
        9.5.    Latin America
        9.6.    Middle East & Africa

10.    Competitive Landscape
         10.1.    Introduction
         10.2.    Key Growth Strategies
         10.3.    Competitive Benchmarking
         10.4.    Market Share Analysis (2020)
                     10.4.1.    Eurofins Scientific S.E.
                     10.4.2.    Illumina, Inc.
                     10.4.3.    Perkinelmer, Inc.
                     10.4.4.    GENEWIZ, Inc.
                     10.4.5.    Foundation Medicine, Inc. (Subsidiary of F. Hoffmann-La Roche AG)

11.    Company Profiles
         11.1.    Illumina, Inc.
                     11.1.1.    Business Overview
                     11.1.2.    Financial Overview
                     11.1.3.    Service Portfolio
                     11.1.4.    Strategic Developments
         11.2.    QIAGEN N.V.
                     11.2.1.    Business Overview
                     11.2.2.    Financial Overview
                     11.2.3.    Service Portfolio
         11.3.    PerkinElmer, Inc.
                     11.3.1.    Business Overview
                     11.3.2.    Financial Overview
                     11.3.3.    Service Portfolio
         11.4.    Eurofins Scientific S.E.
                     11.4.1.    Business Overview
                     11.4.2.    Financial Overview
                     11.4.3.    Service Portfolio
                     11.4.4.    Strategic Developments
         11.5.    Macrogen, Inc.
                     11.5.1.    Company Overview
                     11.5.2.    Financial Overview
                     11.5.3.    Service Portfolio
                     11.5.4.    Strategic Developments
         11.6.    LGC Limited
                     11.6.1.    Business Overview
                     11.6.2.    Financial Overview
                     11.6.3.    Service Portfolio
                     11.6.4.    Strategic Developments
         11.7.    GENEWIZ, Inc.
                     11.7.1.    Business Overview
                     11.7.2.    Financial Overview
                     11.7.3.    Service Portfolio
                     11.7.4.    Strategic Developments
         11.8.    Beijing Genomics Institute (BGI)
                     11.8.1.    Business Overview
                     11.8.2.    Service Portfolio
                     11.8.3.    Strategic Developments
         11.9.    Scigenom Labs Pvt., Ltd.
                     11.9.1.    Business Overview
                     11.9.2.    Service Portfolio
         11.10.    Medgenome Inc.
                     11.10.1.    Business Overview
                     11.10.2.    Service Portfolio
                     11.10.3.    Strategic Developments
         11.11.    DNA Link, Inc.
                     11.11.1.    Business Overview
                     11.11.2.    Service Portfolio
         11.12.    Otogenetics Corporation
                     11.12.1.    Business Overview
                     11.12.2.    Service Portfolio
         11.13.    Novogene Co., Ltd.
                     11.13.1.    Business Overview
                     11.13.2.    Service Portfolio
                     11.13.3.    Strategic Developments
         11.14.    CD Genomics
                     11.14.1.    Business Overview
                     11.14.2.    Service Portfolio
                     11.14.3.    Strategic Developments
         11.15.    SeqLL Inc.
                     11.15.1.    Business Overview
                     11.15.2.    Financial Overview
                     11.15.3.    Service Portfolio
         11.16.    Foundation Medicine, Inc. (Subsidiary of F. Hoffmann-La Roche AG)
                     11.16.1.    Business Overview
                     11.16.2.    Financial Overview
                     11.16.3.    Service Portfolio
                     11.16.4.    Strategic Developments

12.    Appendix
         12.1.    Questionnaire
         12.2.    Available Customization

List of Tables

Table 1    NGS Services Market Drivers: Impact Analysis (2021–2028)
Table 2    Currently Available Targeted Therapies and Corresponding Biomarkers
Table 3    Estimated Number of New Cancer Cases, by Type (2020)
Table 4    NGS Services Market Restraints: Impact Analysis (2021–2028)
Table 5    Global NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 6    Global Targeted Sequencing Services Market Size, by Country/Region, 2019–2028 (USD Million)
Table 7    Global RNA Sequencing Services Market Size, by Country/Region, 2019–2028 
(USD Million)
Table 8    Global De Novo Sequencing Services Market Size, by Country/Region, 2019–2028 (USD Million)
Table 9    Global Exome Sequencing Services Market Size, by Country/Region, 2019–2028 
(USD Million)
Table 10    Global Chip Sequencing Services Market Size, by Country/Region, 2019–2028 (USD Million)
Table 11    Global Methyl Sequencing Services Market Size, by Country/Region, 2019–2028 (USD Million)
Table 12    Global Whole-Genome Sequencing Services Market Size, by Country/Region, 2019–2028 (USD Million)
Table 13    Global Other NGS Services Market Size, by Country/Region, 2019–2028 (USD Million)
Table 14    Global NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 15    Global Sbs-based NGS Services Market Size, by Country/Region, 2019–2028 (USD Million)
Table 16    Global Ios-based NGS Services Market Size, by Country/Region, 2019–2028 (USD Million)
Table 17    Global Smart Technology-based NGS Services Market Size, by Country/Region, 2019–2028 (USD Million)
Table 18    Global Nanopore Technology-based NGS Services Market Size, by Country/Region, 2019–2028 (USD Million)
Table 19    Global Other Technologies-based NGS Services Market Size, by Country/Region, 2019–2028 (USD Million)
Table 20    Global NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 21    Global NGS Services Market Size for Diagnostics, by Country/Region, 2019–2028 (USD Million)
Table 22    Global NGS Services Market Size for Drug Discovery, by Country/Region, 2019–2028 (USD Million)
Table 23    Tumor Markers in Different Cancer Types
Table 24    Global NGS Services Market Size for Biomarker Discovery, by Country/Region, 2019–2028 (USD Million)
Table 25    Global NGS Services Market Size for Agriculture & Animal Research, by Country/Region, 2019–2028 (USD Million)
Table 26    Global NGS Services Market Size for Other Applications, by Country/Region, 2019–2028 (USD Million)
Table 27    Global NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 28    Global NGS Services Market Size for Hospitals & Clinics, by Country/Region, 2019–2028 (USD Million)
Table 29    Global NGS Services Market Size for Pharmaceutical & Biotechnology Companies, by Country/Region, 2019–2028 (USD Million)
Table 30    Global NGS Services Market Size for Academic & Research Institutes, by Country/Region, 2019–2028 (USD Million)
Table 31    Global NGS Services Market Size for Other End Users, by Country/Region, 2019–2028 (USD Million)
Table 32    Global NGS Services Market Size, by Country/Region, 2019–2028 (USD Million)
Table 33    North America: NGS Services Market Size, by Country, 2019–2028 (USD Million)
Table 34    North America: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 35    North America: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 36    North America: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 37    North America: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 38    U.S.: Key Macroindicators
Table 39    U.S.: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 40    U.S.: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 41    U.S.: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 42    U.S.: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 43    Canada: Key Macroindicators
Table 44    Canada: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 45    Canada: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 46    Canada: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 47    Canada: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 48    Europe: NGS Services Market Size, by Country/Region, 2019–2028 (USD Million)
Table 49    Europe: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 50    Europe: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 51    Europe: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 52    Europe: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 53    Germany: Key Macroindicators
Table 54    Germany: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 55    Germany: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 56    Germany: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 57    Germany: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 58    France: Key Macroindicators
Table 59    France: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 60    France: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 61    France: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 62    France: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 63    U.K.: Key Macroindicators
Table 64    U.K.: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 65    U.K.: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 66    U.K.: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 67    U.K.: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 68    Italy: Key Macroindicators
Table 69    U.K.: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 70    Italy: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 71    Italy: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 72    Italy: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 73    Spain: Key Macroindicators
Table 74    Spain: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 75    Spain: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 76    Spain: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 77    Spain: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 78    Estimated Number of New Cancer Cases From 2020 To 2030
Table 79    Roe: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 80    Roe: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 81    Roe: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 82    Roe: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 83    Asia-Pacific: NGS Services Market Size, by Country/Region, 2019–2028 (USD Million)
Table 84    Asia-Pacific: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 85    Asia-Pacific: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 86    Asia-Pacific: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 87    Asia-Pacific: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 88    Japan: Key Macroindicators
Table 89    Japan: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 90    Japan: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 91    Japan: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 92    Japan: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 93    China: Key Macroindicators
Table 94    China: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 95    China: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 96    China: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 97    China: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 98    India: Key Macroindicators
Table 99    India: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 100    India: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 101    India: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 102    India: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 103    Estimated Number of New Cancer Cases From 2020 To 2030
Table 104    Roapac: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 105    Roapac: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 106    Roapac: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 107    Roapac: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 108    Latin America: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 109    Latin America: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 110    Latin America: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 111    Latin America: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 112    Middle East & Africa: NGS Services Market Size, by Type, 2019–2028 (USD Million)
Table 113    Middle East & Africa: NGS Services Market Size, by Technology, 2019–2028 (USD Million)
Table 114    Middle East & Africa: NGS Services Market Size, by Application, 2019–2028 (USD Million)
Table 115    Middle East & Africa: NGS Services Market Size, by End User, 2019–2028 (USD Million)
Table 116    Recent Developments, by Company, 2018—2021

List of Figures

Figure 1    Research Process
Figure 2    Key Secondary Sources
Figure 3    Primary Research Techniques
Figure 4    Key Executives Interviewed
Figure 5    Breakdown of Primary Interviews (Supply-Side & Demand-Side)
Figure 6    Market Size Estimation
Figure 7    Global Next-generation Sequencing Services Market Size, by Application, 2021 Vs. 2028 (USD Million)
Figure 8    Global Next-generation Sequencing Services Market Size, by Type, 2021 Vs. 2028 (USD Million)
Figure 9    Global Next-generation Sequencing Services Market Size, by Technology, 2021 Vs. 2028 (USD Million)
Figure 10    Global Next-generation Sequencing Services Market Size, by End User, 2021 Vs. 2028 (USD Million)
Figure 11    Next-generation Sequencing Services Market, by Geography
Figure 12    Market Dynamics
Figure 13    Cost of Genome Sequencing: 2010–2020
Figure 14    Global NGS Services Market Size, by Type, 2021–2028 (USD Million)
Figure 15    Number of Manuscripts Featuring RNA Sequencing Per Year on Pubmed
Figure 16    Global NGS Services Market Size, by Technology, 2021–2028 (USD Million)
Figure 17    Global NGS Services Market Size, by Application, 2021–2028 (USD Million)
Figure 18    New Molecular Entity (NME) Approvals Per Year
Figure 19    Global NGS Services Market Size, by End User, 2021–2028 (USD Million)
Figure 20    Global Biopharmaceutical R&D Spending, 2014–2020 (USD Billion)
Figure 21    Global NGS Services Market Size, by Geography, 2021–2028 (USD Million)
Figure 22    North America: NGS Services Market Snapshot
Figure 23    Pharmaceutical R&D Expenditure in the U.S.
Figure 24    Pharmaceutical Industry Research and Development in Europe (2019)
Figure 25    Europe: NGS Services Market Snapshot
Figure 26    Number of Biotechnology Firms in Italy, 2008-2019
Figure 27    R&D Spending by Pharmaceutical Industry in Spain, 2015-2019 (USD Million)
Figure 28    Pharmaceutical R&D Spending in Roe (2019)
Figure 29    Asia-Pacific: NGS Services Market Snapshot
Figure 30    Key Growth Strategies Adopted by Leading Players, 2018—2021
Figure 31    NGS Services: Competitive Benchmarking (Based on Service Type)
Figure 32    NGS Services: Competitive Benchmarking (Based on Geography)
Figure 33    Market Share Analysis: NGS Services Industry, 2020
Figure 34    Illumina, Inc.: Financial Overview, 2020
Figure 35    Qiagen N.V.: Financial Overview, 2020
Figure 36    Perkinelmer, Inc.: Financial Overview, 2020
Figure 37    Eurofins Scientific S.E.: Financial Overview, 2020
Figure 38    Macrogen, Inc.: Financial Overview, 2020
Figure 39    LGC Limited: Financial Overview, 2020
Figure 40    Brooks Automation, Inc.: Financial Overview, 2020
Figure 41    SeqLL Inc.: Financial Overview, 2020
Figure 42    F. Hoffmann-La Roche AG.: Financial Overview, 2020

  Request Sample
Related Research